Magnetic resonance imaging and spectroscopy;Imagerie et spectroscopie par resonance magnetique

Presse Medicale

Volumn 26, Issue 32, 1997, Pages 1547-1553

  Cabanis, E A ^a   Tourbah, A ^c   Iba Zizen, M T ^c   Stievenart, J L ^c   Lyon Caen, O ^b  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Centre Hospitalier des Quinze Vingts ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BRAIN BARRIER; DEMYELINATION; GLIOSIS; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; PATHOPHYSIOLOGY;

HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS;

EID: 0031586431     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Cabanis EA, Bourgeois H, Iba-zizen MT et al. L'Imagerie en Ophtalmologie. Rapport Annuel de la Société Française d'Ophtalmologie, Masson, Paris 1996.
2. e éd., Masson, Paris, Milan 1997.
3. Lee KH, Hashimoto S, Hooge JP et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis : a prospective 2-year follow-up with comparison of clinical evaluation, evoked potential, oligoclonal banding, and CT. Neurology 1991 ; 41:657-60.
4. Beck RW, Arrington J, Murtagh FR et al. The optic neuritis study group : brain magnetic imaging in acute optic neuritis : experience of the optic neuritis study group. Arch Neurol 1993 ; 50:841-6.
5. Morrissey SP, Miller DH, Kendall BE et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestiive of multiple sclerosis. A 5-year follow-up study. Brain 1993 ; 116:135-46.
6. Fazekas F, Kleinart R, Offenbacher H et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR 1991 ; 12:915-21.
7. Paty DW, Oger JJF, Kastrukoff LF et al. MRI in the diagnosis of MS : a prospective study with comparison of clinical evaluation, evoked potential, oligoclonal banding and CT. Neurology 1988 ; 38:180-5.
8. Barkhof F, Filippi M. Can MRI be a predictor of long term clinical outcome for MS ? Int MSJ 1995 ; 2:4-9.
9. Matthews PM, Pioro E, Narayanan S et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996 ; 119:715-22.
10. Tourbah A, Stievenart JL, Iba-Zizen MT, Zannoli G, Lyon-Caen O, Cabanis EA. In vivo localized NMR proton spectroscopy of normal appearing white matter in patients with multiple sclerosis. J Neuroradiol 1996 ; 23:49-55.
11. Koopmans RA, Li DKB, Grochowski E, Cutler PJ, Paty DW Benign versus chronic progressive multiple sclerosis : Magnetic resonance imaging features. Ann Neurol 1989 ; 25:74-81.
12. Richards TL. Proton MR spectroscopy in MS : Value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR 1991 ; 157:1073-8.
13. Arnold DL, De Stefano N, Collins DL et al. Maging of axonal damage in multiple sclerosis. Neurology 1994 ; (suppl 2), A 340.
14. Ormerod IE, Miller DH, McDonald WI. The role of NMR imaging in the assessment of multiple sclerosi and isolated neurological lesions. Brain 1987 ; 110:1579-616.
15. Stewart WA, Hall LD, Berry K, Paty DW. Correlation between NMR scan and brain slice : Data in multiple sclerosis. Lancet 1984 ; 2:412.
16. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Rain CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993 ; 34:661-9.
17. Pozzilli C, Fieschi C, Perani D et all. Relationship between corpus callosum atrophy and cerebral metabolic-asymmetries in multiple sclerosis. J Neurol Sci 1992 ; 112:51-7.
18. Mann U, Staedt D, Kappos L, Wense AV, Haubitz I. Correlation of MRI findins and neuropsychological results in patients with multiple sclerosis. Psychiatry Res 1989 ; 29:293-4.
19. Anzola GP, Bevilacqua L, Cappa SF et al. Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment : Correlation with magnetic resonance imaging. J Neurol Neurosurg Psychiatry 1990 ; 53:142-5.
20. Thompson AJ, Kermode AG, MacManus DG et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. Br Med J 1990 ; 300:631-4.
21. Van Walderveen MMA, Barkhof F, Hommes OR et al. Correlating MRI and clinical disease activity in multiple sclerosis : Relevance of hypointense lesions on short-TR/short-TE (T1weighted) spin-echo images. Neurology 1995 ; 45:1684-90.
22. Silver NC, Barker GJ, MacManus DG, Miller DH. Magnetisation transfer ratio in the cervical cord in multiple sclerosis. Multiple Sclerosis 1996 ; 2:30-1.
23. Dousset V, Grossman RI, Ramer KN et al. Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging. Radiology 1992 ; 182:483-91.
24. MacKay AL, Whittall KP, Cover KS, Li DK, Paty DW. In vivo T2 relaxation measurements of brain may provide myelin concentration. Society of Magnetic Resonance in Medicine, 10th Annual Meeting, Book of Abstracts, San Francisco, Vol. 1, p. 917, Aug. 1991.
25. McFarland HF, Frank JA, Albert PS et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992 ; 32:758-66.
26. Nauta JJP, Thompson AJ, Barkhof F, Miller DH. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients : statistical power of parallel groups and crossover designs. J Neurol Sci 1994 ; 122:6-14.